According to diabetes news today, diabetes drug liraglutide could be better at promoting weight loss than orlistat and placebo, when combined with regular exercise and a healthy diet . The drug, the second in the incretin mimetic class, was launched after exenatide.
The diabetic drug was found to reduce weight more than placebo and orlistat over a 20 week period. Some 76% of those surveyed lost over 5% of body weight with a higher dose of liraglutide. This compared to some 30% on placebo and 44% on orlistat.
However, according to the study, more of those taking liraglutide had a greater rate of nausea and vomiting side effects, described by researchers as transient mild to moderate. The research team included professor Michael Lean from the University of Glasgow.

Get our free newsletters

Stay up to date with the latest news, research and breakthroughs.

You May Also Like

Top diabetes professor drafts risk assessment document for frontline COVID-19 staff

The health and wellbeing of frontline NHS staff has been prioritised among…

Coronavirus: UK instructed to stay at home this weekend

Health Secretary Matt Hancock has said that staying at home this weekend…

Twice daily dairy intakes could reduce type 2 diabetes risk

Eating cheese, yoghurt or eggs twice a day could help lower the…